Document is current
Any future updates will be listed below
-
Authors
Baur, Katharina https://orcid.org/0009-0004-2460-2118
Buser, Andreas https://orcid.org/0000-0002-7942-6746
Jeker, Lukas T. https://orcid.org/0000-0002-3359-8796
Khanna, Nina https://orcid.org/0000-0002-2642-419X
Läubli, Heinz
Heim, Dominik
Dirks, Jan C.
Widmer, Corinne C.
Volken, Thomas https://orcid.org/0000-0002-1490-011X
Passweg, Jakob R.
Holbro, Andreas
- License Information
-
More Information
Article History
Received: 23 April 2023
Revised: 9 May 2023
Accepted: 6 June 2023
First Online: 17 June 2023
Competing interests
: LTJ is a co-founder and board member of and holds equity in Cimeio Therapeutics AG a biotech company developing engineered cellular therapies. LTJ’s activities related to Cimeio are unrelated to this study.
